{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:17:58Z","timestamp":1795004278162,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI145400"],"award-info":[{"award-number":["AI145400"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI060549"],"award-info":[{"award-number":["AI060549"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Burroughs Wellcome Fund- Investigators In Pathogenesis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76680-4","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:13:50Z","timestamp":1786518830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection"],"prefix":"10.1038","volume":"17","author":[{"given":"Michelle N.","family":"Vu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Elias","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea R.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumari G.","family":"Lokugamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-3229","authenticated-orcid":false,"given":"Yiyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani P.","family":"Ahearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Hazell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah K.","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa M.","family":"McLeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Schindewolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-7458","authenticated-orcid":false,"given":"Jessica A.","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan T.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-0076","authenticated-orcid":false,"given":"Patricia A.","family":"Crocquet-Valdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8016-8556","authenticated-orcid":false,"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-8380","authenticated-orcid":false,"given":"Mehul S.","family":"Suthar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1931-4555","authenticated-orcid":false,"given":"William K.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2874-5990","authenticated-orcid":false,"given":"Andrew L.","family":"Routh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7485-3167","authenticated-orcid":false,"given":"Kenneth S.","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8803-7606","authenticated-orcid":false,"given":"Vineet D.","family":"Menachery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"76680_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/d41586-021-03552-w","volume":"600","author":"E Callaway","year":"2021","unstructured":"Callaway, E. Heavily mutated Omicron variant puts scientists on alert. Nature 600, 21 (2021).","journal-title":"Nature"},{"key":"76680_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adu8067","volume":"17","author":"S Kumar","year":"2025","unstructured":"Kumar, S. et al. The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins. Sci. Transl. Med 17, eadu8067 (2025).","journal-title":"Sci. Transl. Med"},{"key":"76680_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.chom.2021.02.020","volume":"29","author":"JA Plante","year":"2021","unstructured":"Plante, J. A. et al. The variant gambit: COVID-19\u2019s next move. Cell Host Microbe 29, 508\u2013515 (2021).","journal-title":"Cell Host Microbe"},{"key":"76680_CR4","doi-asserted-by":"publisher","first-page":"e1010627","DOI":"10.1371\/journal.ppat.1010627","volume":"18","author":"BA Johnson","year":"2022","unstructured":"Johnson, B. A. et al. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. PLoS Pathog. 18, e1010627 (2022).","journal-title":"PLoS Pathog."},{"key":"76680_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02091-24","volume":"99","author":"KG Lokugamage","year":"2025","unstructured":"Lokugamage, K. G. et al. Convergent evolution in nucleocapsid facilitated SARS-CoV-2 adaptation for human infection. J. Virol. 99, e0209124 (2025).","journal-title":"J. Virol."},{"key":"76680_CR6","doi-asserted-by":"publisher","first-page":"e3003115","DOI":"10.1371\/journal.pbio.3003115","volume":"23","author":"HC Kubinski","year":"2025","unstructured":"Kubinski, H. C. et al. Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation. PLoS Biol. 23, e3003115 (2025).","journal-title":"PLoS Biol."},{"key":"76680_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/v4061011","volume":"4","author":"S Belouzard","year":"2012","unstructured":"Belouzard, S., Millet, J. K., Licitra, B. N. & Whittaker, G. R. Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein. Viruses 4, 1011\u20131033 (2012).","journal-title":"Viruses"},{"key":"76680_CR8","doi-asserted-by":"publisher","first-page":"e1009857","DOI":"10.1371\/journal.ppat.1009857","volume":"17","author":"MN Vu","year":"2021","unstructured":"Vu, M. N. & Menachery, V. D. Binding and entering: COVID finds a new home. PLOS Pathog. 17, e1009857 (2021).","journal-title":"PLOS Pathog."},{"key":"76680_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.virol.2017.12.009","volume":"517","author":"BA Johnson","year":"2018","unstructured":"Johnson, B. A., Graham, R. L. & Menachery, V. D. Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses. Virology 517, 30\u201337 (2018).","journal-title":"Virology"},{"key":"76680_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41586-022-04690-5","volume":"605","author":"MM DeGrace","year":"2022","unstructured":"DeGrace, M. M. et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature 605, 640\u2013652 (2022).","journal-title":"Nature"},{"key":"76680_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00999-6","volume":"9","author":"A Moreno","year":"2024","unstructured":"Moreno, A. et al. Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity. NPJ Vaccines 9, 201 (2024).","journal-title":"NPJ Vaccines"},{"key":"76680_CR12","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S1473-3099(25)00007-6","volume":"25","author":"MS Suthar","year":"2025","unstructured":"Suthar, M. S. et al. The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant. Lancet Infect. Dis. 25, e122\u2013e123 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"76680_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"B Coutard","year":"2020","unstructured":"Coutard, B. et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 176, 104742 (2020).","journal-title":"Antivir. Res."},{"key":"76680_CR14","doi-asserted-by":"publisher","unstructured":"Johnson, B. A. et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature https:\/\/doi.org\/10.1038\/s41586-021-03237-4 (2021).","DOI":"10.1038\/s41586-021-03237-4"},{"key":"76680_CR15","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. bioRxiv, 2021.2008.2012.456173 https:\/\/doi.org\/10.1101\/2021.08.12.456173 (2021).","DOI":"10.1101\/2021.08.12.456173"},{"key":"76680_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41564-021-00908-w","volume":"6","author":"TP Peacock","year":"2021","unstructured":"Peacock, T. P. et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat. Microbiol 6, 899\u2013909 (2021).","journal-title":"Nat. Microbiol"},{"key":"76680_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205690119","volume":"119","author":"MN Vu","year":"2022","unstructured":"Vu, M. N. et al. QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis. Proc. Natl. Acad. Sci. 119, e2205690119 (2022).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"76680_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/22221751.2020.1756700","volume":"9","author":"S-Y Lau","year":"2020","unstructured":"Lau, S.-Y. et al. Attenuated SARS-CoV-2 variants with deletions at the S1\/S2 junction. Emerg. Microbes Infect. 9, 837\u2013842 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"76680_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00467-25","volume":"99","author":"AL Morgan","year":"2025","unstructured":"Morgan, A. L. et al. The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2. J. Virol. 99, e0046725 (2025).","journal-title":"J. Virol."},{"key":"76680_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115929","volume":"44","author":"K Baid","year":"2025","unstructured":"Baid, K. et al. Early innate immune response and evolution of a SARS-CoV-2 furin cleavage site inactive variant in bat cells. Cell Rep. 44, 115929 (2025).","journal-title":"Cell Rep."},{"key":"76680_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","volume":"592","author":"JA Plante","year":"2021","unstructured":"Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592, 116\u2013121 (2021).","journal-title":"Nature"},{"key":"76680_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.chom.2022.01.006","volume":"30","author":"A Escalera","year":"2022","unstructured":"Escalera, A. et al. Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission. Cell Host Microbe 30, 373\u2013387.e377 (2022).","journal-title":"Cell Host Microbe"},{"key":"76680_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110829","volume":"39","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. Cell Rep. 39, 110829 (2022).","journal-title":"Cell Rep."},{"key":"76680_CR24","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","volume":"34","author":"J Hadfield","year":"2018","unstructured":"Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121\u20134123 (2018).","journal-title":"Bioinformatics"},{"key":"76680_CR25","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3201\/eid2606.200516","volume":"26","author":"J Harcourt","year":"2020","unstructured":"Harcourt, J. et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg. Infect. Dis. 26, 1266\u20131273 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"76680_CR26","doi-asserted-by":"publisher","unstructured":"Gao, C. et al. SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors. bioRxiv, 2020.2007.2029.227462 https:\/\/doi.org\/10.1101\/2020.07.29.227462 (2020).","DOI":"10.1101\/2020.07.29.227462"},{"key":"76680_CR27","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1021\/acs.analchem.0c03173","volume":"93","author":"M Sanda","year":"2021","unstructured":"Sanda, M., Morrison, L. & Goldman, R. N- and O-Glycosylation of the SARS-CoV-2 Spike Protein. Anal. Chem. 93, 2003\u20132009 (2021).","journal-title":"Anal. Chem."},{"key":"76680_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","volume":"27","author":"X Xie","year":"2020","unstructured":"Xie, X. et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe 27, 841\u2013848 e843 (2020).","journal-title":"Cell Host Microbe"},{"key":"76680_CR29","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s41596-021-00491-8","volume":"16","author":"X Xie","year":"2021","unstructured":"Xie, X. et al. Engineering SARS-CoV-2 using a reverse genetic system. Nat. Protoc. 16, 1761\u20131784 (2021).","journal-title":"Nat. Protoc."},{"key":"76680_CR30","doi-asserted-by":"publisher","unstructured":"Peacock, T. P. et al. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein. bioRxiv, 2021.2012.2031.474653 https:\/\/doi.org\/10.1101\/2021.12.31.474653 (2022).","DOI":"10.1101\/2021.12.31.474653"},{"key":"76680_CR31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"76680_CR32","doi-asserted-by":"publisher","unstructured":"Phadke, K. S., Higdon, N. B. A. & Bellaire, B. H. <em>In vitro<\/em> comparison of SARS-CoV-2 variants. bioRxiv, 2023.2003.2011.532212 https:\/\/doi.org\/10.1101\/2023.03.11.532212 (2023).","DOI":"10.1101\/2023.03.11.532212"},{"key":"76680_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277\u2013283 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"76680_CR34","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"C-L Hsieh","year":"2020","unstructured":"Hsieh, C.-L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501\u20131505 (2020).","journal-title":"Science"},{"key":"76680_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq1945","volume":"14","author":"RL Hajnik","year":"2022","unstructured":"Hajnik, R. L. et al. Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models. Sci. Transl. Med 14, eabq1945 (2022).","journal-title":"Sci. Transl. Med"},{"key":"76680_CR36","doi-asserted-by":"publisher","first-page":"e0264723","DOI":"10.1371\/journal.pone.0264723","volume":"17","author":"Z Mustafa","year":"2022","unstructured":"Mustafa, Z., Kalbacher, H. & Burster, T. Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein. PLOS ONE 17, e0264723 (2022).","journal-title":"PLOS ONE"},{"key":"76680_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.abn8939","volume":"377","author":"S Yuan","year":"2022","unstructured":"Yuan, S. et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Science 377, 428\u2013433 (2022).","journal-title":"Science"},{"key":"76680_CR38","doi-asserted-by":"publisher","unstructured":"McCormack, C. P. et al. Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types. bioRxiv, 2023.2003.2015.529513 https:\/\/doi.org\/10.1101\/2023.03.15.529513 (2023).","DOI":"10.1101\/2023.03.15.529513"},{"key":"76680_CR39","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"76680_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli, A. M. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol. 21, 162\u2013177 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"76680_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.146134","volume":"814","author":"V Papanikolaou","year":"2022","unstructured":"Papanikolaou, V. et al. From delta to Omicron: S1-RBD\/S2 mutation\/deletion equilibrium in SARS-CoV-2 defined variants. Gene 814, 146134 (2022).","journal-title":"Gene"},{"key":"76680_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2381","volume":"32","author":"LB Shrestha","year":"2022","unstructured":"Shrestha, L. B., Foster, C., Rawlinson, W., Tedla, N. & Bull, R. A. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev. Med. Virol. 32, e2381 (2022).","journal-title":"Rev. Med. Virol."},{"key":"76680_CR43","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","volume":"3","author":"D Deming","year":"2006","unstructured":"Deming, D. et al. Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants. PLOS Med. 3, e525 (2006).","journal-title":"PLOS Med."},{"key":"76680_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67001-2","volume":"17","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y. et al. SARS-CoV-2 EndoU-ribonuclease regulates RNA recombination and impacts viral fitness. Nat. Commun. 17, 280 (2025).","journal-title":"Nat. Commun."},{"key":"76680_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00957-2","volume":"9","author":"RL Hajnik","year":"2024","unstructured":"Hajnik, R. L. et al. Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants. NPJ Vaccines 9, 160 (2024).","journal-title":"NPJ Vaccines"},{"key":"76680_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","volume":"15","author":"M Baiersdorfer","year":"2019","unstructured":"Baiersdorfer, M. et al. A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA. Mol. Ther. Nucleic Acids 15, 26\u201335 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"76680_CR47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68479","volume":"10","author":"E Jaworski","year":"2021","unstructured":"Jaworski, E. et al. Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants. eLife 10, e68479 (2021).","journal-title":"eLife"},{"key":"76680_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"76680_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 27, 491\u2013499 (2017).","journal-title":"Genome Res."},{"key":"76680_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02749-21","volume":"12","author":"A Vanderheiden","year":"2021","unstructured":"Vanderheiden, A. et al. CCR2 Signaling Restricts SARS-CoV-2 Infection. mBio 12, e0274921 (2021).","journal-title":"mBio"},{"key":"76680_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113965","volume":"43","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity. Cell Rep. 43, 113965 (2024).","journal-title":"Cell Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76680-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76680-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76680-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:03:33Z","timestamp":1789038213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76680-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76680"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76680-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.D.M. has filed a patent on the reverse genetic system and reporter SARS-CoV-2. M.N.V. and V.D.M. have filed a provisional patent on a stabilized SARS-CoV-2 spike protein. Other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9668"}}